Early Changes of Diabetes Parameters After Obesity Therapy
ECODO
1 other identifier
interventional
30
1 country
1
Brief Summary
The aim of the study is to investigate, if bariatric surgery or the related caloric restriction causes the significant improvement of glucose metabolism, which has been found in bariatric patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2015
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 4, 2015
CompletedFirst Posted
Study publicly available on registry
September 17, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2019
CompletedMay 17, 2018
May 1, 2018
3.8 years
September 4, 2015
May 14, 2018
Conditions
Outcome Measures
Primary Outcomes (2)
Change of insulin
Blood insulin is measured during a Mixed Meal Tolerance Test (MMTT). It is used to calculate the Homeostasis Model Assessment (HOMA) and Matsuda Insulin Sensitivity Index
Within 5 days after surgery or 5 days after start of caloric restriction
Change of blood glucose
Blood glucose is measured during a Mixed Meal Tolerance Test (MMTT). It is used to calculate the Homeostasis Model Assessment (HOMA) and Matsuda Insulin Sensitivity Index
Within 5 days after surgery or 5 days after start of caloric restriction
Other Outcomes (10)
Changes regarding markers of glucose metabolism
Within 5 days after surgery or 5 days after start of caloric restriction
Changes of body weight
Within 5 days after surgery or 5 days after start of caloric restriction
Changes of blood lipids
Within 5 days after surgery or 5 days after start of caloric restriction
- +7 more other outcomes
Study Arms (3)
LSG group
EXPERIMENTALLaparoscopic sleeve gastrectomy
LRYGB group
EXPERIMENTALLaparoscopic Roux-en-Y gastric bypass
Control group
OTHERCaloric restriction
Interventions
The surgical procedure and aftercare is indicated and performed according to the routine clinical setting of the Hospital. Patients stay 5 days stationary after surgical treatment. They receive a defined easy digestible diet, starting with liquid and mash food.
The surgical procedure and aftercare is indicated and performed according to the routine clinical setting of the Hospital. Patients stay 5 days stationary after surgical treatment. They receive a defined easy digestible diet, starting with liquid and mash food.
Patients of the control group do not undergo surgical treatment. They undergo a caloric restriction diet for 5 days. This diet is adapted to the postoperative diet of the patients included in the two other groups.
Eligibility Criteria
You may qualify if:
- BMI (Body Mass Index) ≥ 35 kg/m2
- Clinical diagnosis of type II diabetes or impaired glucose metabolism (Prediabetes: HbA1c \> 5,7%, fasting glucose in capillary blood \> 110 mg/dl - diagnosed by blood glucose test at the first study examination)
- Regarding the patients of the surgical groups: Indication to surgical therapy of obesity (laparoscopic sleeve gastrectomy or Roux-en-Y gastric bypass). The indication to surgery is independent of the study. The surgeon decides about that in the clinical routine according to the German S3 guideline.
- Written consent to participate int he study
You may not qualify if:
- Medication use which affects glucose metabolism, except for diabetes medication (for example: glucocorticoids)
- Insulin need \>1,0 IU/kg/d
- Experimental diabetes medication within the last three months
- Pregnancy
- Gastrointestinal diseases
- Uncontrolled hypo- or hyperthyroidism
- Status after bariatric or other gastrointestinal surgery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Hohenheimlead
- University Hospital Tuebingencollaborator
- Karl-Olga-Krankenhaus Stuttgartcollaborator
Study Sites (1)
University of Hohenheim
Stuttgart, Germany
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Stephan C. Bischoff, Prof.
Department of Nutritional Medicine, University of Hohenheim, Stuttgart, Germany
- STUDY DIRECTOR
Alfred Königsrainer, Prof.
Department of General, Visceral, and Transplant Surgery, University Hospital Tübingen, Germany
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 4, 2015
First Posted
September 17, 2015
Study Start
July 1, 2015
Primary Completion
May 1, 2019
Study Completion
July 1, 2019
Last Updated
May 17, 2018
Record last verified: 2018-05